InterventionsHuman trial462 participants44 weeksRandomised trialMulticentre

Efficacy and Safety of Chemically Synthesized Semaglutide Injection (HD1916) for the Treatment of Obesity: A Multicenter, Randomized, Phase III Trial

Diabetes, Obesity & Metabolism

The paper

Peking University People's Hospital

Diabetes, Obesity & Metabolism · 7 Oct 2026

doi.org/10.1111/dom.71354PubMed 42839752